Pedram Paragomi

Dr. Pedram Paragomi

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2019 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
BMBassem Matta
Bassem Matta
AGAmir Gougol
Amir Gougol
XGXiaotian Gao
Xiaotian Gao
NDNageshwar Reddy Duvvur
Nageshwar Reddy Duvvur
RTRupjyoti Talukdar
Rupjyoti Talukdar
GPGeorgios I Papachristou
Georgios I Papachristou

3 July 2023 in Hepatology Communications
Verified
Journal Article
Open access
JBJaideep Behari
Jaideep Behari
AGAmir Gougol
Amir Gougol
RWRenwei Wang
Renwei Wang
HLHUNG LUU
HUNG LUU
PPPedram Paragomi
Pedram Paragomi
Jian-Min YuanJian-Min Yuan
Jian-Min Yuan
Background: HCC can develop in the absence of cirrhosis in patients with NAFLD. We aimed to estimate the incidence of HCC in patients with NAFLD with and without cirrhosis or advanced liver fibrosis. Methods: We performed a cohort study to determine the incidence of HCC in patients with NAFLD identified by the International Classification of Diseases 9/10 codes in the electronic health records of a US health care system between 2004 and 2018. The incidence of HCC was stratified by the presence or absence of cirrhosis and by the Fibrosis-4 index (FIB-4) at the time of HCC diagnosis. Results: Of 47,165 patients with NAFLD aged 40–89 years, 981 (2.1%) developed HCC (mean follow-up 3.4 y). Among patients with HCC, 842 (85.8%) had cirrhosis, while 139 (14.2%) did not. Of the 139 patients with HCC without cirrhosis-related diagnostic codes, 26 (2.7%) had FIB-4 >2.67 (advanced fibrosis likely), whereas 43 (4.4%) had FIB-4 < 1.30 (excluding advanced fibrosis). The annual incidence of HCC in patients with NAFLD with and without cirrhosis was 23.6 and 1.1 per 1000 person-years, respectively. Among patients without cirrhosis, the annual incidence of HCC was 2.8 per 1000 person-years with FIB-4 >2.67 and 0.7 per 1000 person-years with FIB-4 <1.30. Patients with NAFLD and cirrhosis were 31.8 times (95% CI, 23.3–43.4) more likely to develop HCC than those without cirrhosis and FIB-4 <1.30, after adjustment for age and sex. Conclusions: Patients with NAFLD without cirrhosis nor advanced fibrosis have a low incidence of HCC.

7 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
PPPedram Paragomi
Pedram Paragomi
BDBashir Dabo
Bashir Dabo
CPClaudio Pelucchi
Claudio Pelucchi
RBRosella Bonzi
Rosella Bonzi
ABAbdulaziz T. Bako
Abdulaziz T. Bako
HLHUNG LUU
HUNG LUU
Background. Gastric cancer (GC) is the fifth most common type of cancer and the fourth most common cause of cancer-related mortality. Although the risk of GC and peptic ulcer disease (PUD) is known to be increased by H. pylori infection, evidence regarding the direct relationship between PUD and GC across ethnicities is inconclusive. Therefore, we investigated the association between PUD and GC in the Stomach cancer Pooling (StoP) consortium. Methods. History of peptic ulcer disease was collected using a structured questionnaire in 11 studies in the StoP consortium, including 4106 GC cases and 6922 controls. The two-stage individual-participant data meta-analysis approach was adopted to generate a priori. Unconditional logistic regression and Firth’s penalized maximum likelihood estimator were used to calculate study-specific odds ratios (ORs) and 95% confidence intervals (CIs) for the association between gastric ulcer (GU)/duodenal ulcer (DU) and risk of GC. Results. History of GU and DU was thoroughly reported and used in association analysis, respectively, by 487 cases (12.5%) and 276 controls (4.1%), and 253 cases (7.8%) and 318 controls (6.0%). We found that GU was associated with an increased risk of GC (OR = 3.04, 95% CI: 2.07–4.49). No association between DU and GC risk was observed (OR = 1.03, 95% CI: 0.77–1.39). Conclusions. In the pooled analysis of 11 case–control studies in a large consortium (i.e., the Stomach cancer Pooling (StoP) consortium), we found a positive association between GU and risk of GC and no association between DU and GC risk.

21 March 2023 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
YYYi-Chuan Yu
Yi-Chuan Yu
PPPedram Paragomi
Pedram Paragomi
AJAizhen Jin
Aizhen Jin
RWRenwei Wang
Renwei Wang
RSRobert E. Schoen
Robert E. Schoen
HLHUNG LUU
HUNG LUU
Background: Colorectal cancer is common cancer with a high mortality rate. Low-carbohydrate diet (LCD) score holistically evaluates the LCD pattern from carbohydrate, protein, and fat intake. Epidemiologic data of LCD–colorectal cancer association are sparse. Methods: We evaluated the associations between LCD (i.e., total, animal- and plant-based) and colorectal cancer risk in the Singapore Chinese Health Study, a population-based prospective cohort study including 61,321 Chinese in Singapore who were 45 to 74 years old at baseline. Cox proportional hazard regression model was used to determine the HRs and respective 95% confidence intervals (CI) for colorectal cancer associated with LCD after adjusting for potential confounders, including age, sex, BMI, physical activity, family history of colorectal cancer, etc. Results: After an average of 19.5 years of follow-up, 2,520 participants developed colorectal cancer (1,608 colon cancer and 912 rectal cancer). Overall, the association between total or plant-based LCD scores with the risk of colorectal, colon, or rectal cancer was null (all Ptrend ≥ 0.28). The animal-based LCD was modestly associated with colon cancer risk (Ptrend = 0.02), but not with rectal cancer. Compared with the lowest quartile, HRs (95% CIs) of colon cancer for quartiles 2, 3, and 4 of animal-based LCD were 1.12 (0.98–1.29), 1.27 (1.10–1.46), and 1.14 (0.99–1.31), respectively. Conclusions: A low-level carbohydrate diet with a high level of animal protein and fat was associated with a moderate increase in the risk of colon cancer among Chinese Singaporeans. Impact: High consumption of animal protein/fat and low consumption of carbohydrates may increase colon cancer risk.

26 August 2021 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
HLHUNG LUU
HUNG LUU
PPPedram Paragomi
Pedram Paragomi
AJAizhen Jin
Aizhen Jin
RWRenwei Wang
Renwei Wang
NNNithya Neelakantan
Nithya Neelakantan
Jian-Min YuanJian-Min Yuan
Jian-Min Yuan
Background: Limited research has been conducted on the effect of quality diet index (QDI), which represents a comprehensive assessment of healthy diet quality and quantity, on pancreatic cancer risk in Asian populations. Methods: Using data from the Singapore Chinese Health Study, a prospective cohort of 63,257 middle-aged or older Chinese men and women, four QDI scores: the Alternative Health Eating Index-2010 (AHEI-2010), the alternate Mediterranean Diet (aMED), the Dietary Approaches to Stop Hypertension (DASH), and the Heathy Diet Indicator (HDI), at baseline were calculated. After 25 years of follow-up, 311 cohort participants developed pancreatic cancer. Cox proportional hazard regression method was used to estimate HR and 95% confidence interval (CI) for pancreatic cancer associated with higher QDI scores. Results: Higher scores of AHEI-2010, aMED, and DASH were significantly associated with lower pancreatic cancer risk (all Ptrend < 0.05). Compared with the lowest quartile, HRs (95% CIs) of pancreatic cancer for the highest quartiles of AHEI-2010, aMED, and DASH scores were 0.65 (0.46–0.90), 0.57 (0.38–0.85), and 0.66 (0.46–0.95), respectively. These associations were more apparent among men. Overall, there was no statistically significant difference in the QDI–pancreatic cancer risk association between subgroups stratified by levels of body mass index, history of diabetes, and smoking status. Conclusions: Higher QDI scores were significantly associated with reduced risk of pancreatic cancer. Impact: The consistent results across multiple QDIs shows that adherence to a healthy diet may lower pancreatic cancer risk, suggesting that dietary modification may be a promising approach for primary prevention of pancreatic cancer.

17 September 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PPPedram Paragomi
Pedram Paragomi
AHAlice Hinton
Alice Hinton
IPIoannis Pothoulakis
Ioannis Pothoulakis
RTRupjyoti Talukdar
Rupjyoti Talukdar
RKRakesh Kochhar
Rakesh Kochhar
GPGeorgios I Papachristou
Georgios I Papachristou